Shoji-Hosaka Emi, Kobayashi Yukari, Wakitani Masako, Uchida Kazuhisa, Niwa Rinpei, Nakamura Kazuyasu, Shitara Kenya
Department of Antibody Research, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., Machida-shi, Tokyo 194-8533.
J Biochem. 2006 Dec;140(6):777-83. doi: 10.1093/jb/mvj207. Epub 2006 Oct 12.
Fucose removal from complex-type oligosaccharide of human IgGs results in a major enhancement of Fc-dependent cellular cytotoxicity. The aim of this study was to determine the effect of fucose removal on the effector function of another class of clinically important molecules that can effect cellular cytotoxicity, Fc fusion proteins. The receptors chosen for study were TNF receptor II and LFA-3, both of which have therapeutic significance. The fucosylated versions of these fusion proteins were produced in unmodified CHO cells, whereas the nonfucosylated counterparts were produced in CHO cells with alpha-1,6-fucosyltransferase, an enzyme required for fucosylation, knocked-out. Whilst binding activity of TNFRII-Fc and LFA-3-Fc were unchanged by fucose-removal, nonfucosylated Fc fusion proteins exhibited significantly higher Fc receptor gammaIIIa-binding and increased Fc-mediated cytotoxicity on target cells compared to fucosylated counterparts. Notably, in case of TNFRII-Fc, only the nonfucosylated protein exhibited potent Fc dependent cytotoxicity to transmembrane TNF-alpha expressing cells. These results prove that enhancement of Fc dependent cellular cytotoxicity by fucose-removal is effective in not only whole IgG but also Fc fusion proteins, and thus widens the potential of Fc-fusion proteins as therapeutic candidates.
从人免疫球蛋白的复合型寡糖中去除岩藻糖可显著增强Fc依赖性细胞毒性。本研究的目的是确定去除岩藻糖对另一类可影响细胞毒性的临床重要分子——Fc融合蛋白的效应器功能的影响。选择用于研究的受体是肿瘤坏死因子受体II(TNF receptor II)和淋巴细胞功能相关抗原3(LFA-3),二者均具有治疗意义。这些融合蛋白的岩藻糖基化版本在未修饰的中国仓鼠卵巢细胞(CHO细胞)中产生,而非岩藻糖基化的对应物则在敲除了岩藻糖基化所需的α-1,6-岩藻糖基转移酶的CHO细胞中产生。虽然去除岩藻糖并未改变TNFRII-Fc和LFA-3-Fc的结合活性,但与岩藻糖基化的对应物相比,非岩藻糖基化的Fc融合蛋白表现出显著更高的Fc受体γIIIa结合能力,并增强了对靶细胞的Fc介导的细胞毒性。值得注意的是,就TNFRII-Fc而言,只有非岩藻糖基化蛋白对表达跨膜TNF-α的细胞表现出强大的Fc依赖性细胞毒性。这些结果证明,去除岩藻糖增强Fc依赖性细胞毒性不仅对完整的免疫球蛋白有效,对Fc融合蛋白也有效,从而拓宽了Fc融合蛋白作为治疗候选药物的潜力。